Physician Telemedicine Settlement: The Practice Moved, State Boundaries Stayed

A New Jersey doctor agreed to pay $60,000 in a telemedicine controlled substances settlement over allegations that she prescribed to patients in Oklahoma and Texas without the required authority. She had moved her main practice and transferred her Drug Enforcement Administration registration, yet the government alleged missing authority in both patient states. For someone handling credentials or prescriptions, that is the point of the case: a registration on file still has to match the work being done.

The U.S. Attorney’s Office for the Western District of Oklahoma announced the civil Controlled Substances Act settlement on April 26, 2017. The allegations concerned prescriptions issued between January 1, 2013, and March 8, 2016, for Schedule II, III, and IV controlled substances. The DEA’s Office of Diversion Investigation investigated the case.

From a Texas Office to Oklahoma Telemedicine

The physician initially treated Oklahoma patients at her Texas office. After moving her main practice to New Jersey, she began providing medical services to Oklahoma patients through telemedicine and continued seeing patients in Texas.

The state line had always been there. What changed was where the Oklahoma patients received care. According to the government’s allegations, she was prescribing controlled substances to patients in a state that had not licensed her to practice medicine.

The Government Identified Separate Gaps in Authority

The allegations distinguished a medical license from federal and state controlled-substance registrations. Each had a different place in the government’s account, and the alleged gaps differed between Oklahoma and Texas.

Oklahoma Medical Licensure

The United States alleged that the physician was not licensed to practice medicine in Oklahoma when she prescribed controlled substances for patients there. That allegation concerned permission to practice medicine, separate from the controlled-substance registrations also at issue.

Drug Enforcement Administration Registration

The federal-registration allegations reached both patient states. The government alleged that the physician lacked the required Drug Enforcement Administration registration for the Oklahoma prescribing and lacked a DEA registration for Texas.

The registration moved with the main practice. The patient care still reached across state lines. A credentialing employee may see the transfer, while prescription records show where the patients continued receiving care.

Oklahoma Bureau of Narcotics Registration

The United States also alleged that the physician lacked the required Oklahoma Bureau of Narcotics registration. That was a separate state controlled-substance registration, alongside the medical-license and DEA-registration allegations. For someone who maintained those credentials, the distinction is concrete: the medical board, Drug Enforcement Administration and Oklahoma Bureau of Narcotics were separate authorities.

Patient Location Is Part of the Clinical Arrangement

Telemedicine separates where the professional works from where the patient receives care. In the industry’s terminology, the patient’s location is the originating site and the professional’s location is the distant site. A change to one does not move the other. The Federation of State Medical Boards’ April 2022 model policy describes the patient-location principle: a physician must be licensed or otherwise appropriately authorized by the medical board where the patient is located.

The distinction also matters inside a telehealth business. The professional supplies the clinical assessment and prescription. A management company may handle scheduling, billing and technology, while a platform supplies the communications system. Patient intake and encounter records can identify location. Professional-registration records identify the clinician’s authority.

Those responsibilities can sit in different hands. Someone scheduling a remote appointment may see where the patient will be. Someone maintaining the physician’s credentials may see the registration history.

Interstate Medical Licensure Compact and the Pandemic Exception

The Interstate Medical Licensure Compact became operational in April 2017, after the prescribing period at issue here. The compact’s licensing process expedites separate state licenses. It does not replace them with a national physician license.

That distinction was part of the design. The 2015 Journal of American Physicians and Surgeons commentary FSMB Interstate Medical Licensure Compact: An Economist’s View describes the primary state’s board checking a physician’s qualifications so other participating states can grant licenses to physicians who meet their requirements.

The Drug Enforcement Administration’s March 25, 2020 letter described a state-registration exception that began on March 23, 2020. When we examine a practice’s history with an insider, the dates help show what changed in the work and what changed in the permission to do it.

Prescribing Authority and the Claim for Payment

This settlement resolved civil penalty claims under the Controlled Substances Act. It concerned the physician’s authority to prescribe.

Healthcare payment rules sit alongside prescribing authority. Medicare’s rules about where it will pay for a remote service address reimbursement. State medical authorization and controlled-substance registration address the professional’s authority. A health care business may have records about both.

A separate case shows where the payment question can lead. In the Healthy Meds Pharmacy settlement, the pharmacy agreed to pay $350,000 to resolve False Claims Act allegations involving TRICARE claims and telemedicine-policy prescriptions. That case concerned the pharmacy’s billing. The physician’s state-registration settlement concerned her prescribing authority.

What an Insider Can Connect

The valuable inside view connects the patient, the prescription and the authority used on the relevant date. In this case, the government’s allegations depended on those connections across the physician’s move.

A credentialing employee may know when a registration transferred. A clinician or practice employee may know where the patients were and how services continued. Prescription records can connect that work to the physician who authorized it. If public payment is also involved, billing records add the claim and the entity that submitted it.

Your knowledge can explain how those records fit together: which part of the practice moved, which patients continued receiving care and what the business understood about its authority. Our whistleblower experts work with you to build the case around those decisions and the people who understood them.

You Saw Where the Prescriptions Went

If you know how a practice kept prescribing across state lines, speak to one of our Whistleblower Experts about where the prescriptions went. We help turn your knowledge of the patients, credentials and payments into your strongest telehealth whistleblower case, bring in healthcare fraud whistleblower lawyers who understand remote prescribing, and stay beside you through the process. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.